At the news
? NEUTRALIMPACT 3/10 144 filed Oct 7, 2026 at 16:22 ET
Michael J. Farrell, an officer and director of ResMed, filed a Form 144 notice of intent to sell 4,991 shares of common stock, with an estimated aggregate market value of approximately $1,129,637.70. The shares were acquired via stock option exercise on the same date as the filing, and the proposed sale is to be executed through Fidelity Brokerage Services LLC on the NYSE.
- Insider: Michael J. Farrell (Officer, Director)
- Shares to be sold: 4,991 shares of common stock
- Estimated value: ~$1,129,637.70
- Acquisition: Stock option exercise on 10/07/2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access